CNS outcomes of osimertinib plus chemotherapy in patients with EGFR mutation positive lung cancer beyond osimertinib progression von Wong, Wesley KY, Mok, Kevin KS, Tsui, Giselle PC, Chen, Olivia H, Loong, Herbert HF, Chan, Landon L, Yan, Kelvin, Mo, Frankie, Lee, Kirsty WC, Lam, KC, Mok, Florence ST, Johnson, David, Chen, Allen CC, Lam, Benjamin, Lee, Matthew, Mok, Tony SK, Li, Molly SC

Volltext